Krónikus obstruktív tüdőbetegség (COPD): vizsgálatok itt: Lengyelország

In Lengyelország 17 Also abroad 559

17 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.

2. fázisTaking people
A Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
Where
Białystok, Krakow
Életkor
40 év to 75 év
People
606 worldwide
Run by
Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00
3. fázisTaking people
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
Where
Warsaw
Életkor
18 év to 80 év
People
40 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT07555483 · EU 2025-522792-29-00
2. fázisTaking people
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
Where
Bialystok, Bydgoszcz, Chęciny, Elblag, Karczew, Katowice, Komorniki, Ksawerów, Lodz, Ostróda, Piaseczno, Płock, Poznan, Rzeszów, Sosnowiec, Szczecin, Warsaw
Életkor
40 év and over
People
987 worldwide
Run by
AstraZeneca
See details and how to joinNCT07082738
3. fázisTaking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
Where
Bialystok, Chęciny, Krakow, Lodz, Ostrowiec Świętokrzyski, Poznan
Életkor
40 év to 80 év
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00
2/3. fázisTaking people
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
Where
Bydgoszcz, Cracow, Katowice, Ostrowiec Świętokrzyski, Pruszkow, Sosnowiec, Tarnów, Warsaw, Wrocław
Életkor
35 év to 80 év
People
1156 worldwide
Run by
Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00
4. fázisTaking people
A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
Where
Bialystok, Ostrowiec Świętokrzyski, Poznan
Életkor
40 év to 85 év
People
218 worldwide
Run by
Sanofi
See details and how to joinNCT07053423
3. fázisTaking people
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
Where
Bialystok, Elblag, Katowice, Piaseczno, Sosnowiec, Wroclaw
Életkor
40 év to 80 év
People
942 worldwide
Run by
Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00
2. fázisNot yet taking people in Lengyelország
A Randomized, Double-Blind, Placebo-controlled, Parallel Arm, 52-week Study to Assess Efficacy, Safety, Tolerability, and Pharmacokinetics of Two Doses of EXPD-101 in Participants with COPD
Where
Cracow, Gdansk, Katowice, Lodz, Ostrowiec Świętokrzyski, Poznan, Rzeszow, Sochaczew, Warsaw, Wroclaw, Zabrze
Életkor
18 év and over
People
183 worldwide
Run by
Expedition Therapeutics Inc.
See details and how to join2026-525216-34-00 · EU 2026-525216-34-00
3. fázisTaking people
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
Where
Bialystok, Bydgoszcz, Cracow, Gdansk, Poznan, Rzeszów, Sosnowiec, Wroclaw
Életkor
40 év to 80 év
People
981 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT06959095 · EU 2024-520418-22-00
3. fázisTaking people
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Where
Bialystok, Bydgoszcz, Checiny, Chojnice, Cracow, Częstochowa, Inowroclaw, Karczew, Katowice, Kielce, Libiąż, Lodz, Lubin, Lublin, Ostrowiec Świętokrzyski, Piaseczno, Plock, Poznan, Rzeszów, Sieradz, Skorzewo, Słupsk, Sochaczew, Sosnowiec, Szczecin, Torun, Ustroń, Warsaw, Wroclaw
Életkor
40 év to 80 év
People
5250 worldwide
Run by
AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00
3. fázisTaking people
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Where
Bialystok, Bydgoszcz, Chrzanow, Cracow, Karczew, Katowice, Kielce, Lublin, Ostróda, Piaseczno, Plock, Poznan, Pruszkow
Életkor
40 év to 80 év
People
990 worldwide
Run by
AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00
2. fázisTaking people
A study to investigate the effect of AZD6793 in participants with moderate to very severe chronic obstructive pulmonary disease
Where
Bialystok, Bydgoszcz, Checiny, Elblag, Karczew, Katowice, Komorniki, Ksawerów, Lodz, Ostróda, Piaseczno, Plock, Poznan, Rzeszów, Szczecin, Warsaw
Életkor
18 év and over
People
307 worldwide
Run by
AstraZeneca AB
See details and how to join2025-520473-40-00 · EU 2025-520473-40-00
3. fázisTaking people
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
Where
Bialystok, Lodz, Poznan, Rzeszów, Sosnowiec
Életkor
40 év to 75 év
People
1196 worldwide
Run by
GlaxoSmithKline
See details and how to joinNCT07177339 · EU 2025-521108-23-00
1. fázisTaking people
A Study of BBT002 in Healthy Volunteers (HVs) and in Adult Patients With Chronic Obstructive Pulmonary Disease (COPD) or Chronic Rhiosininusitis With Nasal Polyps (CRSwNP)
Where
Bydgoszcz, Cracow, Gdansk, Nadarzyn, Szczecin
Életkor
18 év to 80 év
People
286 worldwide
Run by
Bambusa Therapeutics
See details and how to joinNCT06944925 · EU 2025-523142-28-00
3. fázisCsak meghívásos
Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency
Where
Krakow, Warsaw
Életkor
20 év to 72 év
People
290 worldwide
Run by
Grifols Therapeutics LLC
See details and how to joinNCT02796937
No phaseTaking people
Pulmonary Rehabilitation in Salt Chambers for Patients With COPD
Where
Krakow
Életkor
18 év and over
People
80
Run by
University School of Physical Education, Krakow, Poland
See details and how to joinNCT07122544
2. fázisNot yet taking people in Lengyelország
A Study to Investigate Using Inhaled Fexlamose to Treat Adult Participants Who Have Moderate to Severe COPD
Where
Bialystok, Ostrowiec Świętokrzyski, Wrocław
Életkor
40 év to 80 év
People
100 worldwide
Run by
Aer Therapeutics
See details and how to joinNCT06731959 · EU 2025-523020-50-00